MY133666A - Enzymatic process for stereoselective preparation of therapeutic amides - Google Patents

Enzymatic process for stereoselective preparation of therapeutic amides

Info

Publication number
MY133666A
MY133666A MYPI97001553A MYPI9701553A MY133666A MY 133666 A MY133666 A MY 133666A MY PI97001553 A MYPI97001553 A MY PI97001553A MY PI9701553 A MYPI9701553 A MY PI9701553A MY 133666 A MY133666 A MY 133666A
Authority
MY
Malaysia
Prior art keywords
enzymatic process
stereoselective preparation
formula
preparing
amides
Prior art date
Application number
MYPI97001553A
Other languages
English (en)
Inventor
John Crosby
Robert Anthony Holt
John David Pittam
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of MY133666A publication Critical patent/MY133666A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/11Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/11Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton
    • C07C255/14Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton containing cyano groups and esterified hydroxy groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/02Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/42Hydroxy-carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MYPI97001553A 1996-04-10 1997-04-09 Enzymatic process for stereoselective preparation of therapeutic amides MY133666A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9607458.8A GB9607458D0 (en) 1996-04-10 1996-04-10 Enzymatic process for stereoselective preparation of therapeutic amides

Publications (1)

Publication Number Publication Date
MY133666A true MY133666A (en) 2007-11-30

Family

ID=10791844

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI97001553A MY133666A (en) 1996-04-10 1997-04-09 Enzymatic process for stereoselective preparation of therapeutic amides

Country Status (22)

Country Link
US (2) US6110729A (cs)
EP (1) EP0904400B1 (cs)
JP (3) JP3896162B2 (cs)
KR (1) KR20000005286A (cs)
CN (1) CN1215434A (cs)
AR (1) AR008756A1 (cs)
AT (1) ATE291095T1 (cs)
AU (1) AU723526B2 (cs)
BR (1) BR9708532A (cs)
CA (1) CA2251634A1 (cs)
CZ (1) CZ324698A3 (cs)
DE (1) DE69732772T2 (cs)
GB (1) GB9607458D0 (cs)
IL (1) IL126451A0 (cs)
MY (1) MY133666A (cs)
NO (1) NO984712D0 (cs)
NZ (1) NZ331401A (cs)
PL (1) PL329290A1 (cs)
SK (1) SK140198A3 (cs)
TR (1) TR199802019T2 (cs)
WO (1) WO1997038124A2 (cs)
ZA (1) ZA973019B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1175889A (ja) * 1997-07-15 1999-03-23 Mitsubishi Rayon Co Ltd 光学活性α−トリフルオロメチル乳酸及びその対掌体エステルの製造方法及び精製方法
GB9804648D0 (en) 1998-03-06 1998-04-29 Zeneca Ltd Chemical compounds
GB9805520D0 (en) 1998-03-17 1998-05-13 Zeneca Ltd Chemical compounds
GB9811427D0 (en) 1998-05-29 1998-07-22 Zeneca Ltd Chemical compounds
EP1074539B1 (en) * 1999-08-04 2007-10-17 Sumitomo Chemical Company, Limited Process for producing optically active 3,3,3,-trifluoro-2-hydroxy-2-methylpropionic acid, and salt thereof
JP2003508509A (ja) 1999-09-04 2003-03-04 アストラゼネカ アクチボラグ ピルビン酸デヒドロゲナーゼの阻害剤としてのアミド
MY127036A (en) 1999-09-04 2006-11-30 Astrazeneca Ab Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3- trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity
US6552225B1 (en) 1999-09-04 2003-04-22 Astrazeneca Ab Chemical compounds
EP1422226A1 (en) * 2002-11-25 2004-05-26 Tosoh Corporation Optically active fluorine-containing compounds and processes for their production
JP4529419B2 (ja) * 2002-11-25 2010-08-25 東ソー株式会社 光学活性含フッ素化合物類、及びこれらの製造方法
JP2007217440A (ja) * 2007-06-06 2007-08-30 Mitsubishi Rayon Co Ltd 光学活性α−トリフルオロメチル乳酸の精製方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2541466A (en) * 1949-05-21 1951-02-13 Eastman Kodak Co Alpha-fluoromethyl acrylonitriles and copolymers thereof
JPS59205989A (ja) * 1983-05-09 1984-11-21 Sumitomo Chem Co Ltd 光学活性なアルコ−ル化合物の生化学的製法
DE3528265A1 (de) * 1985-08-07 1987-02-12 Bayer Ag Phosphonsaeureester
US4929760A (en) * 1987-11-24 1990-05-29 Showa Shell Sekiyu Kabushiki Kaisha Fluorine-containing carbonyl compounds and method for preparing the same
JPH03254694A (ja) * 1990-03-01 1991-11-13 Kurita Water Ind Ltd 光学活性な含フッ素アルコールの製造方法
GB9005467D0 (en) * 1990-03-12 1990-05-09 Ici Plc Process for the preparation of optically active intermediates for insecticidal compounds
JP3010497B2 (ja) * 1990-05-31 2000-02-21 チッソ株式会社 光学活性α―ヒドロキシエステル類の製造方法
GB9214120D0 (en) * 1991-07-25 1992-08-12 Ici Plc Therapeutic amides
US5334534A (en) * 1992-04-15 1994-08-02 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Enzymatic preparation of optically active propanolol and β-adrenergic blockers using esterase
JP3133480B2 (ja) * 1992-04-15 2001-02-05 昭和シェル石油株式会社 光学活性ハロゲン含有アルコールの製造方法
JPH08511945A (ja) * 1992-07-08 1996-12-17 ユニケマ・ケミー・ベー・ヴェー カルボン酸と第三アルコールのエステル化法
GB9304256D0 (en) * 1993-03-03 1993-04-21 Chiros Ltd Arylalkanoic acid resolution
GB9309716D0 (en) * 1993-05-12 1993-06-23 Zeneca Ltd Heterocyclic derivatives
BE1007297A3 (nl) * 1993-07-19 1995-05-09 Dsm Nv Werkwijze voor de bereiding van optisch aktieve alcoholen en esters, en alcoholen en esters toegepast en bereid in dergelijke werkwijzen.
GB9322472D0 (en) * 1993-11-01 1993-12-22 Chiros Ltd Chiral compounds and their preparation

Also Published As

Publication number Publication date
AR008756A1 (es) 2000-02-23
ZA973019B (en) 1997-10-10
ATE291095T1 (de) 2005-04-15
AU723526B2 (en) 2000-08-31
DE69732772T2 (de) 2005-10-27
BR9708532A (pt) 1999-08-03
KR20000005286A (ko) 2000-01-25
CA2251634A1 (en) 1997-10-16
JP3896162B2 (ja) 2007-03-22
JP2005287514A (ja) 2005-10-20
DE69732772D1 (de) 2005-04-21
EP0904400A2 (en) 1999-03-31
AU2302897A (en) 1997-10-29
WO1997038124A2 (en) 1997-10-16
WO1997038124A3 (en) 1997-12-18
JP2006345873A (ja) 2006-12-28
EP0904400B1 (en) 2005-03-16
US6110729A (en) 2000-08-29
CN1215434A (zh) 1999-04-28
SK140198A3 (en) 1999-03-12
IL126451A0 (en) 1999-08-17
PL329290A1 (en) 1999-03-15
JP2000509254A (ja) 2000-07-25
CZ324698A3 (cs) 1999-01-13
US6261830B1 (en) 2001-07-17
NZ331401A (en) 2000-06-23
NO984712L (no) 1998-10-09
GB9607458D0 (en) 1996-06-12
TR199802019T2 (xx) 1999-04-21
NO984712D0 (no) 1998-10-09

Similar Documents

Publication Publication Date Title
HUT77925A (hu) Dihidrobenzofuránok, azokat tartalmazó gyógyászati készítmények és eljárás előállításukra
IL109780A0 (en) Saccharin derivative proteolytic enzyme inhibitors, their preparation and pharmaceutical compositions containing them
SG47520A1 (en) New method for the production of 9-amino-6-demethyl-6-deoxytetracycline
AU4815197A (en) Tetraphosphonate bicyclic trisanhydrides
GR3030342T3 (en) Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase.
EP0783002A3 (en) Process for the preparation of dual action inhibitors
MX9709240A (es) Fenilpiridazinonas.
SG52659A1 (en) Saccharin derivative proteolytic enzyme inhibitors
EP0776327A4 (en) NEW MULTIMERIZATION AGENTS
MY133647A (en) Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
DE69428280D1 (de) Verfahren zur herstellung von azetidinonen
PL326271A1 (en) Novel thin catalysts, method of obtaining them and their application as well as crossklinkg compositions containing such novel thin catalysts
BG101110A (en) Substituted pyrimidine compounds and their application
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
MX9604367A (es) Hidroxipiridinonas novedosas.
MY133666A (en) Enzymatic process for stereoselective preparation of therapeutic amides
BG104243A (en) Method for the synthesis of quinoline derivatives
MY117934A (en) Process for the preparation of n-methyl-3-(1-methyl-4- piperidinyl)-1h-indole-5-ethanesulphonamide
EP0666321A3 (en) Process for the production of amide compounds with microorganisms.
BG106002A (en) Process for preparing pesticidal intermediates
IN187760B (cs)
EP1134213A3 (en) Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides
AU6991696A (en) 3-beta-aminoazabicyclo-octane or -nonane naphthamide derivatives as antipsychotic agents
PL343546A1 (en) Processes for preparing intermediates
IT1270660B (it) Procedimento microbiologico per la preparazione di 3-oxo-4-azasteroidi-17beta-carbossi sostituiti e uso dei prodotti come inibitori dell'enzima 5alfa-riduttasi